The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus

This publication has 56 references indexed in Scilit:

• Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
  Current Pharmaceutical Design, 2014
• Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats
  European Journal of Pharmacology, 2004
• Serotonin Receptor Activation Inhibits Sodium Current and Dendritic Excitability in Prefrontal Cortex via a Protein Kinase C-Dependent Mechanism
  Journal of Neuroscience, 2002
• Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment
  Psychopharmacology, 2001
• Behavioral Effects of Cannabinoid Agents in Animals
  Critical Reviews™ in Neurobiology, 1999
• Neurobehavioral effects of Δ9-THC and cannabinoid (CB1) receptor gene expression in mice
  Behavioural Brain Research, 1995
• Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: Influence of reduction in intravenous dosage
  Psychiatry Research, 1994
• Evidence that 5-HT2C receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety
  Psychopharmacology, 1994
• Effect of short‐term serotonin depletion on the efficacy of serotonin neurotransmission: Electrophysiological Studies in the Rat central Nervous System
  Synapse, 1990
• The seed and the soil: effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man.
  British Journal of Clinical Pharmacology, 1981